AKT1 and glioblastoma: Circular RNA expression of the AKT3 gene leads to the development of GBM tumors, and this data support the concept that restoring AKT3-174aa while reducing active AKT may give additional benefits for select GBM patients [113] (Figure 5 and Table 3).